Antibody-drug conjugates as drug carrier systems for bioactive agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-drug conjugates as drug carrier systems for bioactive agents
Authors
Keywords
-
Journal
International Journal of Polymeric Materials and Polymeric Biomaterials
Volume 65, Issue 1, Pages 1-10
Publisher
Informa UK Limited
Online
2015-10-10
DOI
10.1080/00914037.2015.1038818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Drug Conjugates: Preclinical Considerations
- (2015) Gadi G. Bornstein AAPS Journal
- Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy
- (2014) Ravi V. J. Chari et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals
- (2014) Li Qin et al. BMC Cardiovascular Disorders
- Assessment of urinary concentration of cotinine in Chinese pregnant women exposed to environmental tobacco smoke
- (2014) Yajing Lei et al. CHINESE SCIENCE BULLETIN
- A sensitive and specific enzyme immunoassay for detecting tartrazine in human urinary samples
- (2013) Yajing Lei et al. Analytical Methods
- Development and comparison of two competitive ELISAs for the detection of bisphenol A in human urine
- (2013) Yajing Lei et al. Analytical Methods
- Effect of HA14-1 on Apoptosis-Regulating Proteins in HeLa Cells
- (2013) Kanwal Rehman et al. Chemical Biology & Drug Design
- Estimation of Urinary Concentration of Aflatoxin M1in Chinese Pregnant Women
- (2013) Yajing Lei et al. JOURNAL OF FOOD SCIENCE
- Monoclonal antibody-based therapies in cancer: Advances and challenges
- (2013) Puja Sapra et al. PHARMACOLOGY & THERAPEUTICS
- An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2
- (2012) C Andrew Boswell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Antibody–drug conjugates – a perfect synergy
- (2012) John R Adair et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors
- (2012) Christina M. Annunziata et al. INVESTIGATIONAL NEW DRUGS
- Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
- (2012) Muhammad Sajid Hamid Akash et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antibody–drug conjugates: Basic concepts, examples and future perspectives
- (2012) Giulio Casi et al. JOURNAL OF CONTROLLED RELEASE
- Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds
- (2012) Stephen A. Hitchcock JOURNAL OF MEDICINAL CHEMISTRY
- Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody-Drug Conjugate
- (2012) C. A. Boswell et al. JOURNAL OF NUCLEAR MEDICINE
- Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
- (2012) Muhammad Sajid Hamid Akash et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
- (2011) A. D. Ricart CLINICAL CANCER RESEARCH
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
- (2011) Simona Lapusan et al. INVESTIGATIONAL NEW DRUGS
- Synthesis and Evaluation of Hydrophilic Linkers for Antibody–Maytansinoid Conjugates
- (2011) Robert Y. Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of Antibody Conjugates of Phosphate Prodrugs of Cytotoxic DNA Alkylators for the Targeted Treatment of Cancer
- (2011) Robert Yongxin Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analytical methods for physicochemical characterization of antibody drug conjugates
- (2011) Aditya Wakankar et al. mAbs
- Antibody–drug conjugates: targeted drug delivery for cancer
- (2010) Stephen C Alley et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
- (2010) Anjali Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Self-immolative linkers in polymeric delivery systems
- (2010) Christopher A. Blencowe et al. Polymer Chemistry
- Design, Synthesis, and Biological Evaluation of Antibody−Drug Conjugates Comprised of Potent Camptothecin Analogues
- (2009) Patrick J. Burke et al. BIOCONJUGATE CHEMISTRY
- Atherosclerosis profile and incidence of cardiovascular events: a population-based survey
- (2009) Jennifer G Robinson et al. BMC Cardiovascular Disorders
- Antibody-Drug Conjugate Targets
- (2009) B. Teicher CURRENT CANCER DRUG TARGETS
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity
- (2009) S. C. Alley et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
- (2008) Stephen C. Alley et al. BIOCONJUGATE CHEMISTRY
- Effect of garlic on blood pressure: A systematic review and meta-analysis
- (2008) Karin Ried et al. BMC Cardiovascular Disorders
- Antibody-Drug Conjugates for Cancer Therapy
- (2008) Paul J. Carter et al. CANCER JOURNAL
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer
- (2008) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
- The human PDI family: Versatility packed into a single fold
- (2007) Christian Appenzeller-Herzog et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Selection of Reaction Additives Used in the Preparation of Monomeric Antibody−Calicheamicin Conjugates
- (2007) Irwin Hollander et al. BIOCONJUGATE CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started